People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| XEME Biopharma, Inc. | — | Pharmaceuticals | Series A | $10.0M | $309.7M | 2017 |
Anthony C. Tate at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anthony C. Tate on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sunil S. Metkar | 1 | 1 |
| Marius C. Teodorescu | 1 | 1 |
| Richard J. Robb | 1 | 1 |
| Mircea C. Popescu | 1 | 1 |
| Dorel C. Nasui | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.